6505--SAGENT - CIPROFLOXACIN 400 MG/200ML-D5W - BASE+4

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL CMOP OFFICE (36C770)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C77026Q0112

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

SBA

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs, through its National Consolidated Mail Outpatient Pharmacy (CMOP) Office, has issued an award notice for the procurement of Sagent-branded Ciprofloxacin 400 mg/200 mL in D5W solution. This pharmaceutical product falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is classified with Product Service Code 6505, indicating its status as a medical and pharmaceutical supply. The primary objective of this procurement is to ensure a reliable supply of Ciprofloxacin intravenous solution for VA medical facilities, supporting the ongoing healthcare needs of veterans. The contract is structured as a base period with four option years, reflecting a long-term commitment to maintaining consistent access to this critical medication. The intended outcome is to provide high-quality, FDA-approved pharmaceutical products that meet the clinical requirements of VA patients, delivered in accordance with federal standards and regulations. This procurement is set aside for Small Business Administration (SBA) eligible entities, emphasizing the VA’s commitment to supporting small businesses within the pharmaceutical manufacturing sector. Contractors must demonstrate compliance with SBA set-aside requirements and possess the necessary capabilities to manufacture and supply the specified product in the required quantities and packaging. The contracting entity is the National CMOP Office (organization key: 100183245), a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is Jennifer Coleman, who can be reached at [email protected] or by phone at 913-758-9934. The notice remains active as of the posting date, November 8, 2026, and further details, including attachments, are available via the official SAM.gov opportunity listing (Opportunity ID: 6211b7dd72a547fa91bc7bcde8542e2d). Contractors interested in this opportunity should review the requirements for pharmaceutical preparation manufacturing, ensure compliance with SBA set-aside criteria, and be prepared to deliver consistent, high-quality pharmaceutical products over the contract lifecycle. The scope and deliverables are expected to remain constant, focusing on the supply of Ciprofloxacin 400 mg/200 mL-D5W solution for VA medical facilities nationwide.